-
Product Insights
NEC Corp – NEC Innovation Building – Kanagawa
Equip yourself with the essential tools needed to make informed and profitable decisions with our NEC Corp - NEC Innovation Building - Kanagawa report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
NEC – Flatbush Brooklyn Residential Tower – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our NEC - Flatbush Brooklyn Residential Tower - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Lothian Leisure/ NEC Grp – Edinburgh Indoor Arena – Edinburgh
Equip yourself with the essential tools needed to make informed and profitable decisions with our Lothian Leisure/ NEC Grp - Edinburgh Indoor Arena - Edinburgh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
NEC Grp – Birmingham Urban Village Development – City and Borough of Birmingham
Equip yourself with the essential tools needed to make informed and profitable decisions with our NEC Grp - Birmingham Urban Village Development - City and Borough of Birmingham report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Bulgaria NEC/ EVN – Gorna Arda Cascade 170 MW – Smolyan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Bulgaria NEC/ EVN - Gorna Arda Cascade 170 MW - Smolyan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
NEC – 24-01 Queens Plaza Residential Development – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our NEC - 24-01 Queens Plaza Residential Development - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
NEC Dominican Republic – Marti Solar Park 43 MW – Santo Domingo
Equip yourself with the essential tools needed to make informed and profitable decisions with our NEC Dominican Republic - Marti Solar Park 43 MW - Santo Domingo report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
BP Canada Energy/ Devon NEC – Pike 1 In-situ Oil Sands Development – Alberta
Equip yourself with the essential tools needed to make informed and profitable decisions with our BP Canada Energy/ Devon NEC - Pike 1 In-situ Oil Sands Development - Alberta report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
NEC Cap Sol/ Renova/ SMFL Mirai Ptnrs – Reihoku-Amakusa Wind Power Plant 54.6 MW – Kumamoto
Equip yourself with the essential tools needed to make informed and profitable decisions with our NEC Cap Sol/ Renova/ SMFL Mirai Ptnrs - Reihoku-Amakusa Wind Power Plant 54.6 MW - Kumamoto report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Company Profile
![]()
NEC Corp – Company Profile
NEC Corp (NEC) is a provider of information and network technology solutions. The company’s product portfolio comprises servers, equipment, and network systems for telecommunication carriers, automated teller machines, storage devices, broadcasting video systems, supercomputers, personal computers, tablet terminals, aerospace systems, fire and disaster prevention systems, and software. It also offers electronic components and products such as lithium-ion rechargeable batteries, LCD panels, and lighting equipment. NEC offers services, including system integration, support, and outsourcing services. It serves the aviation, aerospace, healthcare,...
Add to Basket -
Product Insights
Dairi Lumber/ Genboku/ Mitsubishi/ NEC Cap Sol/ Osaka Gas/ Renova/ Tokushima Electric Ind – Tokushima Tsuda Biomass Power Plant 74.8 MW – Tokushima
Equip yourself with the essential tools needed to make informed and profitable decisions with our Dairi Lumber/ Genboku/ Mitsubishi/ NEC Cap Sol/ Osaka Gas/ Renova/ Tokushima Electric Ind - Tokushima Tsuda Biomass Power Plant 74.8 MW - Tokushima report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RG-6524 in Small-Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.RG-6524 in Small-Cell Lung Cancer Drug Details:RG-6524 is under development for the treatment of solid tumors,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RG-6524 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.RG-6524 in Solid Tumor Drug Details:RG-6524 is under development for the treatment of solid tumors, small...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RG-6524 in Neuroendocrine Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.RG-6524 in Neuroendocrine CarcinomaDrug Details:RG-6524 is under development for the treatment of solid tumors, small cell...
-
Company Profile
![]()
NEC Software Solutions UK Ltd – Company Profile
NEC Software Solutions UK Ltd (NEC), formerly Northgate Public Services (UK) Limited, is a provider of a software and outsourcing business services. The company offers a wide range of services including document solutions, processing services, health screening services and cloud solutions. It provides business processing services and software solutions such as payment processing or document management to improve the performance of its customers’ business. NEC caters its services to government departments and agencies, local authorities, police and emergency services, hospitals,...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-764532 in Small-Cell Lung Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-764532 in Small-Cell Lung Cancer Drug Details: OBT-620 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-764532 in Neuroendocrine Carcinoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-764532 in Neuroendocrine Carcinoma Drug Details: OBT-620 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABBV-706 in Glioblastoma Multiforme (GBM)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ABBV-706 in Glioblastoma Multiforme (GBM) Drug Details:ABBV-706 is under development for the treatment of recurrent or...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABBV-706 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ABBV-706 in Solid Tumor Drug Details:ABBV-706 is under development for the treatment of recurrent or refractory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABBV-706 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.ABBV-706 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug Details:ABBV-706 is under development for the treatment of recurrent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.